We're Hiring Menu

Our Leadership

Close

Sujay Jadhav, MBA

Chief Executive Officer

Sujay Jadhav is the Chief Executive Officer at Verana Health where he is helping to accelerate the company’s growth and sustainability by advancing clinical trial capabilities, data-as-a-service offerings, medical society partnerships, and data enrichment.

Sujay joins Verana Health with more than 20 years of experience as a seasoned executive, entrepreneur, and global business leader. Most recently, Sujay was the Global Vice President, Health Sciences Business Unit at Oracle, where he ran the organization’s entire product and engineering teams. Before Oracle, Sujay was the CEO of cloud-based clinical research platform goBalto, where he oversaw the acquisition of the company by Oracle. Sujay is also a former executive for the life sciences technology company Model N, where he helped to oversee its transition to a public company.

Sujay holds an MBA from Harvard University and a bachelor’s degree in electronic engineering from the University of South Australia.

Sujay Jadhav, <span>MBA</span>

Why Verana?

“We are at an inflection point in digital health. We now have the opportunity to transform patient care and cure by extracting quality insights from unfiltered, real-world healthcare data. Verana Health is poised to affect real change by defining and delivering the highest standards of data integrity to power healthcare."

Marc Berger

Chief Operations Officer

Marc Berger is Chief Operations Officer at Verana Health. He was previously Senior Vice President at Verana Health and a member of the core leadership team responsible for setting Verana Health’s corporate strategy. He served as the company’s General Counsel and Privacy Officer and was responsible for the company’s legal functions, including corporate, privacy, commercial contracting, health law, and intellectual property activities. As Senior Vice President, he also oversaw Verana Health’s Security & Compliance and People & Culture teams.

Prior to joining Verana Health, Marc was General Counsel at Flatiron Health, where he was a member of the four-person team that negotiated the $2.1B acquisition by Roche. Marc has also served as Vice President and Assistant General Counsel at Medidata Solutions, where he had global responsibility for negotiating agreements with life science companies and partners for Medidata’s clinical trial technology and service offerings.

Marc received his JD and MBA from the University of Miami School of Law, and his BS in Management and International Business from Penn State University.

Marc Berger on LinkedIn
Marc Berger

Why Verana?

I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.

Matthew Roe, MD, MHS

Chief Medical Officer

Matthew Roe, MD, MHS is Chief Medical Officer at Verana Health, where he leads the cross therapeutic medical team working to ensure the clinical validity and scientific integrity of the company’s research. Additionally, Dr. Roe leads Verana Health’s regulatory strategy, which focuses on determining how data curated by Verana Health can be utilized for regulatory decision-making.  A cardiologist and clinical researcher, Dr. Roe joined Verana Health after spending two decades at the Duke University School of Medicine and the Duke Clinical Research Institute (DCRI), the world’s largest academic research organization. At Duke, he focused on research initiatives leveraging real-world data for observational and prospective studies. Dr. Roe was previously a co-principal investigator for the landmark ADAPTABLE trial and also held leadership positions with several diverse registries focusing upon the treatment and outcomes of patients with cardiovascular disease. At the DCRI, Dr. Roe was Senior Investigator as well as the Director of the organization’s Clinical Research Fellowship and Think Tank series. 

Dr. Roe received his MD and MHS degrees from Duke University School of Medicine in 1993 and 2001, respectively. He completed an Internal Medicine residency at Duke University Medical Center in 1996 and a Cardiovascular Fellowship at the Cleveland Clinic Foundation in 1999.

Matthew Roe, MD, MHS on LinkedIn
Matthew Roe, <span>MD, MHS</span>

Why Verana?

I joined Verana Health to contribute to our mission of leveraging real-world data to enable clinicians to provide the highest quality medical care, to improve the health and quality of life of patients across diverse medical conditions, and to catalyze a transformation of clinical research approaches and processes.

Marie-Eve Piche

Chief Financial Officer

Marie-Eve Piche, Verana Health’s Chief Financial Officer, has nearly two decades of financial management experience in public and fast-growing private companies. Marie-Eve was previously the CFO of Pymetrics and built the financial strategy and capabilities that enabled a successful Series B fundraising. She also served as Vice President of Financial Planning and Analysis at AppNexus, where she helped grow revenue by more than six times during her tenure and was on the team that drove the $1.6B acquisition by AT&T. She began her career at General Electric, holding key financial roles at NBC Sports and Telemundo.

Marie-Eve received her dual MBA from Columbia University and London Business School. She also holds a Master’s in economics from McGill University and a B.Com. from H.E.C. Montreal.

Marie-Eve Piche on LinkedIn
Marie-Eve Piche

Why Verana?

Verana Health is a company that is doing ground-breaking work with technology and data, and is being built by a team that works tirelessly to deliver against its commitment to patients. I'm thrilled to contribute to the impact I know this company will make.

Hylton Kalvaria

Chief Business Officer

Hylton Kalvaria is Chief Business Officer, leading Verana Health’s commercial organization, marketing, and major partnership initiatives with medical associations, life science companies, and regulatory bodies. Hylton joins Verana from Flatiron Health, where he founded, built and led the West Coast business, representing half of Flatiron’s commercial activity. In that capacity, Hylton’s team led the design and execution of Flatiron’s first regulatory-grade projects intended for influential stakeholder audiences, including the FDA. Hylton previously held a variety of roles at Genentech and was appointed to lead a CEO-sponsored initiative focused on identifying emerging sources of real-world data and utilizing those data across the Genentech organization, an initiative that led to Roche’s initial investment in Flatiron.

Hylton holds an MBA and BS in Economics from Duke University.

Hylton Kalvaria on LinkedIn
Hylton Kalvaria

Why Verana?

I'm excited to make a big impact on how we generate evidence for new and existing drugs and devices. We have an opportunity to reinvent that process to be more patient and provider focused.

Ann Watson

Senior Vice President,
People & Culture

Ann Watson is Verana Health’s Senior Vice President of People and Culture, bringing a passion for building teams to Verana Health’s next phase of growth. The People & Culture team is responsible for all phases of the employee lifecycle: from finding great people to supporting their development all the way through to the alumni phase. Ann has over twenty years of experience in Human Resources and Talent Acquisition, primarily with small and mid-sized technology organizations. Ann was previously the Chief People Officer at MasterClass, at Varo Bank, and ran the Employee Experiences organization at Fandom. She specializes in growing teams from 50 to 500+, doubling the team multiple years in a row, building infrastructure to scale through the early start-up stage to mid-size maturity and beyond.

Ann has a BA from Santa Clara University and is a member of PeopleTechPartners, an organization devoted to accelerating solutions that drive the future of work.

Ann Watson on LinkedIn
Ann Watson

Why Verana?

In addition to being drawn to the incredible mission of improving patient outcomes, the people are why I chose Verana. It is an incredible privilege to work with this team and I’m very appreciative of the overall lack of jerks. Verana is doing great work with great people!

Sonja Wustrack

Senior Vice President,
Commercial Operations

Sonja Wustrack is Senior Vice President, Commercial Operations at Verana Health, where she brings over 20 years of health research experience, including academic research, public health surveillance, clinical trial technology, and clinical research. Within the biotechnology and pharmaceutical space, she has held positions in delivery, operations management, sales enablement leadership and account management. Most recently at IQVIA, Sonja focused on enhancing customer engagement and demonstrating improved value through for pharma, payors, providers and patients by leveraging real-world data and analytics to innovate clinical trial design and accelerate execution.

Sonja holds an MPH in Epidemiology from the Tulane School of Public Health, and a Bachelor’s degree in biology from Vassar College.

Sonja Wustrack on LinkedIn
Sonja Wustrack

Why Verana?

I am inspired by the mission to get the right medicines to patients, faster. At Verana, we have an unparalleled depth of real-world data, combined with the expert data insights and clinical expertise and supported by technology and advanced analytics, to be a partner in shifting the drug development paradigm by enabling acceleration through innovation.

Kirk Fjeldheim

Senior Vice President, Engineering and Security

Kirk Fjeldheim is Senior Vice President of Engineering and Security, where he is responsible for Verana Health’s data, infrastructure and corporate protection strategies, which include identifying, developing, implementing, and maintaining processes across product and corporate systems. Kirk also manages corporate IT and Compliance. Kirk Fjeldheim brings several decades of experience at high-growth technology companies to Verana Health. Prior to joining Verana Health, Kirk was Chief Information Security Officer at Syapse, Inc. and Chief Information Officer at SugarCRM. As Vice President of IT and Security at Rally Health, he led Security, compliance and IT for more than 1,400 employees and developed and implemented HIPAA compliance and risk management efforts for a customer application reaching 38 million users. He has also held senior IT positions at Zynga, Xsigo Systems, Openwave Systems, and Siebel Systems.

Kirk Fjeldheim on LinkedIn
Kirk Fjeldheim

Why Verana?

Insights from health data are a critical component of improving the lives of people all over the world. I am thrilled to work at a company where technologists and data scientists are working together to improve quality of care and to advance medical research.

Aracelis Torres, PhD, MPH

VP, Quantitative Sciences

Aracelis Torres, PhD, MPH is Vice President of Quantitative Sciences where she oversees the quantitative sciences team working to develop and implement rigorous methodology to generate sound scientific evidence from real-world data. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis. 

Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.

Aracelis Torres, PhD, MPH on LinkedIn
Aracelis Torres, <span>PhD, MPH</span>

Why Verana?

Verana’s mission to rigorously generate insights from real-world data is both inspiring and exciting. It provides a unique opportunity to tackle some of the toughest challenges in clinical research while keeping patients at the forefront of our work.

Lindsey Karberg

Vice President,
Marketing

Lindsey Karberg is Vice President of Marketing where she brings more than 15 years of experience leading groundbreaking marketing and digital innovation efforts for global healthcare organizations, including three successful start-ups. 

Prior to joining Verana Health, Lindsey was the Vice President of Digital Strategy & Innovation at AbbVie where she led an internal digital incubator and innovation consulting arm supporting multiple therapeutic areas. Lindsey originally came to AbbVie (formerly Allergan) through the acquisition of ZELTIQ for $2.4B, leading the consumer and physician digital marketing and digital product strategy for the CoolSculpting brand, pre- and post-acquisition. Prior to that, Lindsey built and ran global digital and marketing communications at Natera, a Silicon Valley-based genetic testing company that went public ($180M IPO) during Lindsey’s time there. Before that, she oversaw digital and consumer marketing efforts for Ultherapy and Cellfina at Ulthera, Inc. to help position the company for a $600 million acquisition by Merz Pharmaceuticals. And, her love for digital health started at Amendola Communications, where she built the agency’s social media arm and supported the marketing and public relations outreach for healthcare information technology clients such as McKesson, Allscripts, RelayHealth, Sage, and more. 

Lindsey holds a B.A. from Arizona State University and an M.S. from Boston University.

Lindsey Karberg on LinkedIn
Lindsey Karberg

Why Verana?

Data has the power to make a positive impact in healthcare. Working for a company that sits at the center of the healthcare data ecosystem is meaningful and motivating. I may not be a clinician, but working here, I, too, can play a role in changing and saving lives.

Yana Nikitina

Vice President of Engineering

Yana Nikitina is Vice President of Engineering, where she leads technology strategy and product development.

Yana brings over two decades of experience of building scalable, compliant, resilient, interoperable products. In the past years, she focused on accelerating growth in the Fintech space (LendingClub, Varo Bank and Braintree/PayPal). Yana held leadership roles in Data Platform, Actionable Insights, Mobile bank app, Payment Processing and Commerce Payment Platform.

Yana holds a BS in Computer Science from UC Davis.

 

Yana Nikitina on LinkedIn
Yana Nikitina

Why Verana?

Verana's mission strongly aligns with my personal values. I believe it will make a positive real-world impact and improve lives and I am excited to advance the application of innovative technologies to accelerate research in medicine.

Michelle McGovern

General Counsel

Michelle McGovern is the General Counsel at Verana Health, where she works to find solutions that help set the market standard for data privacy in an increasingly complex legal environment.  Michelle was previously the Deputy General Counsel at Redesign Health, a venture-backed incubator that, during her tenure, raised $350M, and built, launched and scaled more than two dozen healthcare companies. Michelle also worked at Pfizer, where her roles included supporting clinical trials and pharmacovigilance, building sustainable markets for pharmaceutical products in the developing world, and serving as the North America Legal Lead for Upjohn, Pfizer’s $12B legacy products and generics business.

Michelle completed Northwestern University’s accelerated journalism degree program, graduating in four years, magna cum laude, with a Bachelor’s of Science and Master’s of Science in Journalism, and received her JD, cum laude, from Northwestern University’s Pritzker School of Law. Michelle has been credentialed by the International Association of Privacy Professionals as a Certified Information Privacy Manager. Michelle is also the President of the Board of Directors of 826NYC, a charity that helps under-resourced youth write their own paths forward, regardless of circumstance.

Michelle McGovern on LinkedIn
Michelle McGovern

Why Verana?

It is a privilege to work for a company that strives to improve the lives of patients, while serving as a steward of their health information. The importance of what we do, and of who we serve, inspires me to approach legal questions with both creativity and care.

Sujay Jadhav, MBA Chief Executive Officer
Marc Berger Chief Operations Officer Marc Berger on LinkedIn
Matthew Roe, MD, MHS Chief Medical Officer Matthew Roe, MD, MHS on LinkedIn
Marie-Eve Piche Chief Financial Officer Marie-Eve Piche on LinkedIn
Hylton Kalvaria Chief Business Officer Hylton Kalvaria on LinkedIn
Ann Watson Senior Vice President,
People & Culture
Ann Watson on LinkedIn
Sonja Wustrack Senior Vice President,
Commercial Operations
Sonja Wustrack on LinkedIn
Kirk Fjeldheim Senior Vice President, Engineering and Security Kirk Fjeldheim on LinkedIn
Aracelis Torres, PhD, MPH VP, Quantitative Sciences Aracelis Torres, PhD, MPH on LinkedIn
Lindsey Karberg Vice President,
Marketing
Lindsey Karberg on LinkedIn
Yana Nikitina Vice President of Engineering Yana Nikitina on LinkedIn
Michelle McGovern General Counsel Michelle McGovern on LinkedIn

Our Board

David W. Parke II, MD (Executive Chairman)

Chief Executive Officer,
American Academy of Ophthalmology

Brook Byers

Founding Partner,
Kleiner, Perkins, Caufield & Byers

Michael T. Sheppard, CPA, CAE

Chief Executive Officer,
American Urological Association

James C. Stevens, MD, FAAN

President,
American Academy of Neurology

Julie Sunderland

Co-Founder and Managing Director,
Biomatics Capital Partners

Krishna Yeshwant, MD

Managing Partner,
GV

Brendan Bulik-Sullivan (Observer)

Partner,
GV

Eli Casdin (Observer)

Chief Investment Officer and Founder,
Casdin Capital

Our Advisors

Mark Blumenkranz, MD

Co-Founder,
Verana Health and Lagunita Biosciences

Theodore Leng, MD

Medical Advisor

Jennifer Cook

Strategic Advisor

Steven Schwartz, MD

Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA

Our Investors

Verana Health is backed by leading institutional investors and industry veterans:

Google Ventures
Casdin Capital
Define Ventures
Biomatics Capital
Lagunita Biosciences
Revelation Partners

Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.